Chondrocyte S100/Calgranulins and RAGE in Osteoarthritis
Chondrocyte S100/Calgranulins and RAGE in Osteoarthritis
批准号:
7433195
负责人:
Robert A. Terkeltaub
金额:
$23.21万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-01 至 2010-05-31
关键词:
AgeAgingAlzheimer&aposs DiseaseAttenuatedBindingCD36 geneCalcium BindingCartilageChondrocytesCollagen Type XDegenerative DisorderDegenerative polyarthritisDiabetes MellitusDisease ProgressionEF Hand MotifsEF-Hand DomainHeadHeterotrimeric GTP-Binding ProteinsHumanHypertrophyIL8 geneIn VitroInflammationInflammatoryIntegral Membrane ProteinInvasiveJointsKneeLeukocyte L1 Antigen ComplexLigandsLinkMAP Kinase GeneMAPK14 geneMediatingMediator of activation proteinModelingMolecularMolecular ConformationMonomeric GTP-Binding ProteinsMusMutationPathogenesisPathway interactionsProteoglycanRecombinantsRelative (related person)ReportingResearch PersonnelRoleS100 ProteinsS100A11 geneSeveritiesSignal TransductionSiteSymptomsTestingTherapeutic InterventionTissuesWorkattenuationcalcificationcollagenase 3congeniccytokinehuman HDAC4 proteinhuman MAPK14 proteinhuman S100A11 proteinin vivomitogen-activated protein kinase p38novelprogramsprotein protein interactionreceptorreceptor for advanced glycation endproductsrepairedsrc-Family Kinasestransglutaminase 2
中文摘要
描述(由申请人提供):低级别关节内炎症促进骨关节炎(OA)的症状和疾病进展。晚期糖基化终产物多配体受体(RAGE)与几种与低级别组织炎症和衰老相关的骨骼外退行性疾病有关,包括糖尿病和阿尔茨海默病。RAGE配体包括可发挥炎症细胞因子样作用的calgranulin/S100蛋白。关节软骨细胞表达RAGE, RAGE和S100A11在OA软骨中表达上调。S100A11诱导软骨细胞肥大。此外,CXCL8和TNFa诱导S100A11表达和软骨细胞肥大,并且S100A11-、CXCL8-和TNFa诱导的软骨细胞肥大是rage依赖性的。我们的目的是确定原型软骨细胞calgranulin S100A11如何通过RAGE信号调节体外软骨细胞分化和功能,并确定RAGE在体内OA发病机制中的作用。我们的具体目标是:1)明确S100A11调节软骨细胞分化和功能的分子结构要求。我们将验证S100A11诱导软骨细胞增生性分化、MMP-13和ADAMts5表达和蛋白聚糖损失的假设,其方式需要S100A11的一个或两个钙结合EF手,以及转谷氨酰胺酶2 (TG2)的聚合。2)明确RAGE信号转导S100A11影响软骨细胞分化和功能的机制。我们将验证S100A11诱导rage特异性信号传导的假设,该信号传导促进上游的Rac1和PI3K信号传导至MKK3和p38 MARK活化,随后下游必需的HDAC4耗竭诱导终末肥厚软骨细胞分化。3)通过评估RAGE-/-与同源RAGE+/+小鼠膝关节不稳定模型中的OA严重程度,验证S100A11和RAGE在体内直接介导小鼠OA发病机制的假设。此外,我们将测试RAGE-/-小鼠股骨头软骨移植体是否降低了S100A11和炎症细胞因子诱导的MMP-13和ADAMts5的表达,软骨细胞肥大,以及相对于RAGE+/+移植体的蛋白聚糖损失。这项工作的完成将揭示新的潜在靶点,通过切断炎症与软骨细胞分化和功能的有害改变来治疗OA。
英文摘要
DESCRIPTION (provided by applicant): Low-grade intra-articular inflammation promotes symptoms and disease progression in osteoarthritis (OA). The multiligand Receptor for Advanced Glycation Endproducts (RAGE) is implicated in several extraskeletal degenerative disorders linked to low-grade tissue inflammation and aging, including diabetes mellitus and Alzheimer's Disease. RAGE ligands include calgranulin/S100 proteins that can exert inflammatory cytokine-like effects. Articular chondrocytes express RAGE, and expression of RAGE and S100A11 are up-regulated in OA cartilage. S100A11 induces chondrocyte hypertrophy. Moreover, CXCL8 and TNFa induce S100A11 expression and chondrocyte hypertrophy, and S100A11-, CXCL8-, and TNFa-induced chondrocyte hypertrophy are RAGE-dependent. Our objective is to define how the prototypical chondrocyte calgranulin S100A11 modulates chondrocyte differentiation and function in vitro via RAGE signaling, and to define the role of RAGE in pathogenesis of OA in vivo. We specifically aim to: 1) Define the molecular structural requirements by which S100A11 modulates chondrocyte differentiation and function. We will test the hypothesis that S100A11 induces hypertrophic differentiation, MMP-13 and ADAMts5 expression, and proteoglycans loss in chondrocytes in a manner that requires one or both S100A11 calcium binding EF hands, as well as multimerization by transglutaminase 2 (TG2). 2) Define the mechanism by RAGE signaling transduces S100A11 effects on chondrocyte differentiation and function. We will test the hypothesis that S100A11 induces RAGE-specific signaling that promotes Rac1 and PI3K signaling upstream to MKK3 and p38 MARK activation, followed by essential downstream HDAC4 depletion to induce terminal hypertrophic chondrocyte differentiation. 3) Test the hypothesis that S100A11 and RAGE directly mediate the pathogenesis of murine OA in vivo by assessing OA severity in a knee instability model in RAGE-/- vs. congenic RAGE+/+ mice. Also, we will test RAGE-/- mouse femoral head cartilage explants for reduced S100A11 and inflammatory cytokine-induced MMP-13 and ADAMts5 expression, chondrocyte hypertrophy, and proteoglycans loss relative to RAGE+/+ explants ex vivo. Completion of the work will reveal new potential targets for therapeutic intervention in OA by disconnecting inflammation from deleterious alteration of chondrocyte differentiation and function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intersections of matrix biology with inflammation in a new model of gout
-
批准号:10579760
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Robert A. Terkeltaub
-
依托单位:
Novel Synovial Role in Pathogenesis of Gout
-
批准号:9810080
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2019
-
负责人:Robert A. Terkeltaub
-
依托单位:
Rheumatic Diseases Research Training Grant
-
批准号:8660292
-
项目类别:
-
资助金额:$25.26万
-
财政年份:2013
-
负责人:Robert A. Terkeltaub
-
依托单位:
Rheumatic Diseases Research Training Grant
-
批准号:9699169
-
项目类别:
-
资助金额:$15.18万
-
财政年份:2013
-
负责人:Robert A. Terkeltaub
-
依托单位:
Rheumatic Diseases Research Training Grant
-
批准号:8849851
-
项目类别:
-
资助金额:$22.54万
-
财政年份:2013
-
负责人:Robert A. Terkeltaub
-
依托单位:
Rheumatic Diseases Research Training Grant
-
批准号:9919502
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2013
-
负责人:Robert A. Terkeltaub
-
依托单位:
Rheumatic Diseases Research Training Grant
-
批准号:8475141
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2013
-
负责人:Robert A. Terkeltaub
-
依托单位:
Rheumatic Diseases Research Training Grant
-
批准号:9062290
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2013
-
负责人:Robert A. Terkeltaub
-
依托单位:
Innate Inflammation in Osteoarthritis
-
批准号:8461078
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert A. Terkeltaub
-
依托单位:
Innate Inflammation in Osteoarthritis
-
批准号:8698319
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert A. Terkeltaub
-
依托单位:
Innate inflammation in osteoarthritis
-
批准号:9898282
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert A. Terkeltaub
-
依托单位:
Innate inflammation in osteoarthritis
-
批准号:9351732
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert A. Terkeltaub
-
依托单位:
Project 1: AMPK and Inflammation in Gout
-
批准号:10263204
-
项目类别:
-
资助金额:$28.29万
-
财政年份:2012
-
负责人:Robert A. Terkeltaub
-
依托单位:
Innate Inflammation in Osteoarthritis
-
批准号:8330368
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert A. Terkeltaub
-
依托单位:
Project 1: AMPK and Inflammation in Gout
-
批准号:10017003
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2012
-
负责人:Robert A. Terkeltaub
-
依托单位:
Transglutaminase 2 in Arterial Calcification and Atherosclerosis
-
批准号:7388360
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2008
-
负责人:Robert A. Terkeltaub
-
依托单位:
Transglutaminase 2 in Arterial Calcification and Atherosclerosis
-
批准号:7766945
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2008
-
负责人:Robert A. Terkeltaub
-
依托单位:
Transglutaminase 2 in Arterial Calcification and Atherosclerosis
-
批准号:7625105
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2008
-
负责人:Robert A. Terkeltaub
-
依托单位:
Chondrocyte S100/Calgranulins and RAGE in Osteoarthritis
-
批准号:7233960
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2006
-
负责人:Robert A. Terkeltaub
-
依托单位:
Chondrocyte S100/Calgranulins and RAGE in Osteoarthritis
-
批准号:7137685
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2006
-
负责人:Robert A. Terkeltaub
-
依托单位:
海外基金